Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.047 | 0.4 |
mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.4 |
mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |